Skip to main content
. 2020 Sep 25;11:550593. doi: 10.3389/fpsyt.2020.550593

Table 2.

Efficacy Measures at Baseline and 6-Months in the Two Treatment Groups.

Placebo (32) Probiotics (31) p ANOVA Pla/Pro T0 p ANOVA Pla/Pro T0-T2
Characteristics T0 T2 Change T0-T2 T0 T2 Change T0-T2
Age, mean (SD), y 4.09 (0.97) 4.62 (0.98) 0.52 4.29 (1.22) 4.82 (1.23) 0.53 ns ns
Boys, No. (%) 27 (84.4) 27 (84.4) n. a. 24 (77.4) 24 (77.4) n. a. ns ns
BMI m (DS) 16.06 (1.73) 15.91 (1.76) -0.15 15.95 (1.93) 16.01 (2.18) 0.06 ns ns
Melatonin supplementation n (%) 2 (6.25) 3 (9.7) ns
Vitamin supplementation 3 (9.4) 7 (22.6) ns
ADOS CSS a
Total 6.97 (1.91) 7.00 (1.80) 0.03 6.84 (1.39) 6.19 (1.56) -0.65 ns ns
Social Affect 6.41(2.21) 6.09 (1.82) -0.31 6.26 (1.79) 5.35 (1.56) -0.90 ns ns
Restricted and repetitive behavior 8.22(1.31) 8.53 (1.34) 0.31 7.94 (1.57) 8.23 (1.45) 0.29 ns ns
SCQ b 16.06(5.54) 13.90 (6.19) -2.16 12.83 (6.68) 11.97 (6.71) -0.87 0.042 ns
RBS-R c 22.31 (15.47) 19.13 (12.10) -3.18 18.32 (13.17) 14.37 (8.01) -3.96 ns ns
DQ d , standardized test
General Quotient 62.29 (20.12) 61.14 (20.13) -1.15 65.91 (18.06) 69.27 (20.09) 3.36 ns ns
VABS II e
Composite Score 57.00 (16.74) 59.72 (16.38) 2.72 63.87 (22.12) 67.39 (22.29) 3.52 ns ns
CBCL f
Total Problems 62.84 (10.97) 57.30 (9.05) -5.54 60.94 (9.94) 57.80 (7.92) -3.14 ns ns
PSI g
Total Stress 74.76 (24.98) 61.03 (32.58) -13.72 70.03 (29.63) 66.62 (31.15) -3.41 ns ns
GI Severity Index h
Total 6-GSI 1.38 (1.45) 1.29 (1.19) -0.08 2.06 (2.14) 1.23 (1.48) -0.83 ns ns
Total GSI 2.91 (2.19) 2.16 (1.57) -0.74 3.61 (2.92) 2.53 (2.19) -1.08 ns ns
Linguistic Level i Pla T0-T2 (%) Pro T0-T2 (%)
= =
0 87.50 12.50 9.68 70.97 19.35 ns ns

ADI-R, Autism Diagnostic Interview–Revised; ADOS, Autism Diagnostic Observation Schedule; CBCL, 1.5-5 Child Behavior Checklist 1.5-5; CSS, Calibrated Severity Score; D, Definite Difference; GI, gastrointestinal; GSI, Gastrointestinal Severity Index; IQ, Intelligence Quotient; No., Number; NGI, Non-Gastrointestinal; Pla, Placebo; Pro, Probiotics; P, Probable Difference; PSI, Parental Stress Index; RBS-R, Repetitive Behaviors Scale-Revised; SCQ, Social Communication Questionnaire; SD, Standard Deviation; T, Typical Performance; VABS-II, Vineland Adaptive Behavior Scales-II. is to be understood as worsened compared to the previous evaluation, = is to be understood as unchanged from the previous evaluation, ↑ is to be understood as improved compared to the previous evaluation. Means, and standard deviations are reported.

a

Higher scores indicate greater severity (range of possible scores for Total, Social Affect and Restricted and Repetitive Behavior is 1-10).

b

Higher scores indicate greater severity (range 0-39) with a threshold of 15 compatible for a relevant impairment of social communication (some studies consider 9 in children younger than four years old).

c

Higher scores indicate greater severity of repetitive behaviors (range 0-114).

d

Higher scores indicate greater cognitive ability. Scores around 100 indicate normal intelligence; scores below 70 indicate a developmental delay.

e

Higher scores indicate greater adaptive competences. Scores around 100 indicate normal adaptive capacities; scores below 70 indicate a delay with respect to age.

f

Higher scores indicate greater severity; a score of 63 and above is generally considered clinically significant.

g

Higher scores indicate greater severity of parental stress index caused both by characteristics of the child and by negative experiences about the parenting role (Total Stress).

h

Higher scores indicate greater severity of gastrointestinal symptoms; Total 6-GSI has a range of 0 to 12, Total GSI has a range of 0 to 17.

i

The “Overall Level of Non-Echoed Spoken Language” item (A1 score) of the ADOS-2 was used to differentiate non-verbal (those with absent language or less than 5 words) from verbal children.